YKL-40 expression in CD14+ liver cells in acute and chronic injury

World Journal of Gastroenterology

Volumn 17, Issue 33, 2011, Pages 3830-3835

  Pizano Martínez, Oscar ^a   Yañez Sánchez, Irinea ^a   Alatorre Carranza, Pilar ^a   Miranda Díaz, Alejandra ^a   Ortiz Lazareno, Pablo C ^b   García Iglesias, Trinidad ^a   Daneri Navarro, Adrian ^a   del Mercado, Mónica Vázquez ^a   Fafutis Morris, Mary ^a   Delgado Rizo, Vidal ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA DE OCCIDENTE   (Mexico)

Author keywords

Kupffer cells; Liver cirrhosis; YKL 40

Indexed keywords

CD14 ANTIGEN; GROWTH FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG; YKL 40 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; B LYMPHOCYTE; CELL SELECTION; CELL SUBPOPULATION; CONTROLLED STUDY; FIBROGENESIS; KUPFFER CELL; LIVER BIOPSY; LIVER CELL; LIVER CELL DAMAGE; MACROPHAGE ACTIVATION; MALE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; T LYMPHOCYTE; WESTERN BLOTTING;

EID: 80053896236     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i33.3830     Document Type: Review

References (20)

1. De Ceuninck F, Gaufllier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (cartilage gp-39) induces prolifera-tive events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 2001; 285: 926-931
2. Bernardi D, Podswiadek M, Zaninotto M, Punzi L, Plebani M. YKL-40 as a marker of joint involvement in infamma-tory bowel disease. Clin Chem 2003; 49: 1685-1688
3. Johansen JS, Christoffersen P, Møller S, Price PA, Henrik-sen JH, Garbarsch C, Bendtsen F. Serum YKL-40 is increased in patients with hepatic fbrosis. J Hepatol 2000; 32: 911-920
4. Johansen JS, Drivsholm L, Price PA, Christensen IJ. High serum YKL-40 level in patients with small cell lung cancer is related to early death. Lung Cancer 2004; 46: 333-340
5. Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006; 53: 172-209
6. Sebastiani G, Alberti A. Non invasive fbrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006; 12: 3682-3694
7. Laskin DL, Weinberger B, Laskin JD. Functional heterogeneity in liver and lung macrophages. J Leukoc Biol 2001; 70: 163-170
8. Zheng M, Cai WM, Zhao JK, Zhu SM, Liu RH. Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fbrosis due to schistosomiasis japonica and appraisal of their clinical value. Acta Trop 2005; 96: 148-152
9. Del Pilar Alatorre-Carranza M, Miranda-Díaz A, Yañez-Sánchez I, Pizano-Martínez O, Hermosillo-Sandoval JM, Vázquez-Del Mercado M, Hernández-Hoyos S, Martínez-Abundis R, Fafutis-Morris M, Segura-Ortega J, Delgado-Rizo V. Liver fibrosis secondary to bile duct injury: correlation of Smad7 with TGF-beta and extracellular matrix proteins. BMC Gastroenterol 2009; 9: 81
10. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006; 43: S54-S62
11. Llovet JM, Bartolí R, Planas R, Cabré E, Jimenez M, Urban A, Ojanguren I, Arnal J, Gassull MA. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 1994; 35: 1648-1652
12. Bode C, Bode JC. Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol Clin Exp Res 2005; 29: 166S-171S
13. Szabo G, Mandrekar P, Dolganiuc A. Innate immune response and hepatic infammation. Semin Liver Dis 2007; 27: 339-350
14. Weber LW, Boll M, Stampf A. Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxi-cological model. Crit Rev Toxicol 2003; 33: 105-136
15. Pinzani M, Knauss TC, Pierce GF, Hsieh P, Kenney W, Dubyak GR, Abboud HE. Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. Am J Physiol 1991; 260: C485-C491
16. Johansen JS, Krabbe KS, Møller K, Pedersen BK. Circulating YKL-40 levels during human endotoxaemia. Clin Exp Immunol 2005; 140: 343-348
17. Kzhyshkowska J, Mamidi S, Gratchev A, Kremmer E, Sch-muttermaier C, Krusell L, Haus G, Utikal J, Schledzewski K, Scholtze J, Goerdt S. Novel stabilin-1 interacting chitinase-like protein (SI-CLP) is up-regulated in alternatively activated macrophages and secreted via lysosomal pathway. Blood 2006; 107: 3221-3228
18. Anderson P. Post-transcriptional control of cytokine production. Nat Immunol 2008; 9: 353-359
19. Date M, Matsuzaki K, Matsushita M, Tahashi Y, Furukawa F, Inoue K. Modulation of transforming growth factor beta function in hepatocytes and hepatic stellate cells in rat liver injury. Gut 2000; 46: 719-724
20. Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. Biochem J 2002; 365: 119-126